Delivery Order SPE2DR25D9223-SPE2DR26FFAG8
Award Date 4/16/26
Potential Completion Date 5/7/26
Potential Value $1.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $1,888.62 delivery order to DMS Pharmaceutical Group Inc. on March 4, 2026, for YF-VAX 1 dose vials, with an ultimate completion date of March 25, 2026. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency single-award indefinite delivery contract with a $499.9 billion ceiling supporting pharmaceutical supply to military healthcare facilities worldwide. DMS Pharmaceutical Group Inc....
- The Defense Logistics Agency issued a $1,888.62 delivery order to DMS Pharmaceutical Group Inc. on March 27, 2026, for YF-VAX 1 dose vials, with an ultimate completion date of April 17, 2026. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small...
- The Defense Logistics Agency issued a $1,888.62 delivery order to DMS Pharmaceutical Group Inc. on April 6, 2026, for YF-VAX 1 dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group is a woman-owned small business. The order is issued under the PPV-G GEN V indefinite delivery contract, a Defense Logistics Agency program authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support...
- The Defense Logistics Agency issued a $1,888.62 delivery order to DMS Pharmaceutical Group Inc. on March 6, 2026, for YF-VAX 1 dose vials, with ultimate completion March 27, 2026. This order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business...
- The Defense Logistics Agency issued a $5,665.86 delivery order to DMS Pharmaceutical Group Inc. on April 2, 2026, for YF-VAX 1 dose vials, with ultimate completion on April 23, 2026. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that enables firm fixed-price delivery orders for pharmaceutical products, biologics, and medical consumables supporting Department of Defense healthcare...
- The Defense Logistics Agency issued a $25,181.60 delivery order to DMS Pharmaceutical Group Inc. on March 6, 2026, for YF-VAX 1 dose vials, with an ultimate completion date of March 27, 2026. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract established to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. Place of performance is...
- The Defense Logistics Agency issued a $1,259.08 delivery order to DMS Pharmaceutical Group Inc. on April 8, 2026, for YF-VAX 1 dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is the Defense Logistics Agency's indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group Inc. is a...
- The Defense Logistics Agency issued a $62,954 delivery order to DMS Pharmaceutical Group Inc. on April 10, 2026, for YF-VAX 1 dose vials, with a completion date of May 1, 2026. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical product supply to Department of Defense healthcare facilities worldwide. Place of performance is Park Ridge, Illinois. DMS Pharmaceutical...
- The Defense Logistics Agency issued a $1,259.08 delivery order to DMS Pharmaceutical Group Inc. on April 7, 2026, for YF-VAX 1 dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide. DMS Pharmaceutical Group...
- The Defense Logistics Agency issued a $1,888.62 delivery order to DMS Pharmaceutical Group Inc. on April 7, 2026, for YF-VAX 1 dose vials, with an ultimate completion date of April 28, 2026. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. This delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price calls for pharmaceutical...